Personalized peptide vaccine (Kurume University)

N/A

Report date: 2023/01/07 18:44:08

Base Information

Drug NamePersonalized peptide vaccine (Kurume University)

Drug Alias Namepersonalized peptide vaccine (advanced matastatic bladder cancer)

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsUrinary Bladder NeoplasmsColorectal NeoplasmsBiliary Tract Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesKurume University

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsUrinary Bladder NeoplasmsColorectal NeoplasmsBiliary Tract Neoplasms

Inactive IndicationsN/A

ATC CodeN/A